Serotonin N-acetyltransferase: Mechanism and Inhibition

Author(s): Weiping Zheng, Philip A. Cole

Journal Name: Current Medicinal Chemistry

Volume 9 , Issue 12 , 2002

Become EABM
Become Reviewer

Abstract:

Serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT) catalyzes the rate-limiting step in the biosynthesis of the circadian hormone melatonin from serotonin. Although melatonin was identified 40 years ago, relatively little is known about its (patho)physiological roles, and a solid scientific foundation is still lacking for most therapeutic applications currently claimed for melatonin. The development of potent, specific, and cell permeable inhibitors for AANAT should constitute an important strategy to address these issues. These inhibitors are also potential therapeutics for various sleep / mood disorders. This review will focus on the efforts toward developing in vitro and in vivo AANAT inhibitors, including basic mechanistic studies on AANAT, which have played an important role in design.

Keywords: aanat, serotonin n-acefyltransferase, sleep disorder, mood disorder, aanat inhibitor

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 12
Year: 2002
Page: [1187 - 1199]
Pages: 13
DOI: 10.2174/0929867023370013
Price: $65

Article Metrics

PDF: 9